Ocugen Valuation
OCGN Stock | USD 0.52 0.05 8.77% |
Ocugen is undervalued. Ocugen Inc holds a recent Real Value of $1.95 per share. The prevailing price of the company is $0.52. Our model determines the value of Ocugen Inc from analyzing the company fundamentals such as Shares Owned By Insiders of 1.27 %, return on equity of -1.54, and Current Valuation of 132.55 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Ocugen's valuation include:
Price Book 5.3511 | Enterprise Value | Enterprise Value Ebitda (1.95) | Price Sales 41.2348 | Forward PE 15.2207 |
Undervalued
Today
Please note that Ocugen's price fluctuation is dangerous at this time. Calculation of the real value of Ocugen Inc is based on 3 months time horizon. Increasing Ocugen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ocugen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ocugen Stock. However, Ocugen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.52 | Real 1.95 | Target 6.25 | Hype 0.51 | Naive 0.54 |
The intrinsic value of Ocugen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ocugen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ocugen Inc helps investors to forecast how Ocugen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ocugen more accurately as focusing exclusively on Ocugen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Ocugen's intrinsic value based on its ongoing forecasts of Ocugen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Ocugen's closest peers.
Ocugen Cash |
|
Ocugen Valuation Trend
Knowing Ocugen's actual value is paramount for traders when making sound investment determinations. Using both Ocugen's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Ocugen Total Value Analysis
Ocugen Inc is now forecasted to have valuation of 132.55 M with market capitalization of 167.21 M, debt of 5.16 M, and cash on hands of 101.6 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Ocugen fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
132.55 M | 167.21 M | 5.16 M | 101.6 M |
Ocugen Investor Information
About 25.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.2. Ocugen Inc last dividend was issued on the 30th of September 2019. The entity had 1:60 split on the 30th of September 2019. Based on the analysis of Ocugen's profitability, liquidity, and operating efficiency, Ocugen Inc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Ocugen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ocugen has an asset utilization ratio of 4.92 percent. This suggests that the Company is making $0.0492 for each dollar of assets. An increasing asset utilization means that Ocugen Inc is more efficient with each dollar of assets it utilizes for everyday operations.Ocugen Ownership Allocation
Ocugen owns a total of 292.01 Million outstanding shares. Roughly 73.91 pct. of Ocugen outstanding shares are held by general public with 1.27 % owned by insiders and only 24.82 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Ocugen Profitability Analysis
The company reported the previous year's revenue of 4.05 M. Net Loss for the year was (54.05 M) with loss before overhead, payroll, taxes, and interest of (28.07 M).About Ocugen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Ocugen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Ocugen Inc based exclusively on its fundamental and basic technical indicators. By analyzing Ocugen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Ocugen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ocugen. We calculate exposure to Ocugen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ocugen's related companies.Last Reported | Projected for Next Year | ||
Gross Profit | 4.1 M | 4.3 M | |
Pretax Profit Margin | (13.33) | (14.00) | |
Operating Profit Margin | (13.50) | (14.18) | |
Net Loss | (13.33) | (14.00) | |
Gross Profit Margin | 0.80 | 0.62 |
Ocugen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 271 M | |
Forward Price Earnings | 15.2207 |
Ocugen Current Valuation Indicators
Ocugen's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Ocugen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Ocugen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Ocugen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Ocugen's worth.When determining whether Ocugen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ocugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ocugen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ocugen Inc Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.20) | Revenue Per Share | Quarterly Revenue Growth (0.46) | Return On Assets | Return On Equity |
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.